S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain - Fig 4 by Md. Imran Khan (4853302)

“…<p>(A) Emission of fluorescence spectra of S100A1 titrations showing a decrease in intensity with the addition of S100A4 at μM-level concentrations. …”

Rhodomyrtone dose dependently decreases production of <i>CXCL1</i>, <i>IL-36G</i>, <i>IL-36RN</i>, <i>MMP-13</i>, <i>S100A7</i>, <i>S100A8</i>, and <i>S100A12</i> transcripts by IL-17A/TNF-α-stimulated primary human keratinocytes. by Julalak Chorachoo (5855852)

Annual susceptible and resistant infections per 100,000 people per mechanism in 10 years of time. by Noortje G. Godijk (9148318)

S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain - Fig 2 by Md. Imran Khan (4853302)

“…The cross peaks, which exhibited decreased intensity, are boxed in green. (B) Ribbon diagram showing the structure of S100A1—decreasing residues are labeled on the structure in green.…”

S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain - Fig 1 by Md. Imran Khan (4853302)

“…(B) Ribbon diagram showing the structure of S100A4; intensity decreasing residues are labeled on the structure in cyan.…”

Decrease of excitability in small IB4-positive TG neurons over-expressing TRESK channels. by Zhaohua Guo (383295)

Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”

Decreased proliferation and increased apoptosis in <i>Mab21l2</i> mutant embryos. by Yohei Saito (180130)

“…Scale bars represent 100 µm (A, D, H, K) and 50 µm (N and P). (R) Quantitative RT-PCR for genes regulating cell proliferation and apoptosis (<i>N-myc</i>, <i>Id2</i>, <i>Cyclin D1</i>, <i>Cyclin D2</i>), marker genes of myocardial differentiation (<i>Anf</i>, <i>Chisel</i>, <i>Mlc2v</i>), genes essential for the development of the trabecular myocardium (<i>Erbb2</i>, <i>Erbb4</i>, <i>Bmp10</i>), genes essential for heart development (<i>Nkx2.5</i>, <i>Gata4</i>), and endocardial transcripts (<i>Flk1</i>, <i>Tie1</i>, <i>Tie2</i>) normalized to <i>Gapdh</i> expression using RNA from dissected hearts of E11.5 WT and <i>Mab21l2</i> mutant (−/−) embryos. …”

Restricting cell size decreases [Ca²⁺]_i frequency. by Charles Godbout (540424)

Mice exposed to neonatal hyperoxia have persistent RVH and decreased vessel density at 21d. by Marta Perez (526067)

miR-200c decreases KLOTHO expression in HK-2 cells by translational repression. by Kenichi Morii (6843554)

CaMKII inhibition does not alter dendritic spine density, but decreases dendritic length and complexity. by Jason R. Klug (132807)

Inhibitor treatment decreases capsule production in different pathogenic <i>E. coli</i> serotypes. by Carlos C. Goller (245570)

PLD1 inhibition decreases the c-Myc-dependent dNTP biosynthetic transcriptional program. by Harry E. Taylor (596259)

Reduced ACh-induced vasorelaxation due to decreased SK3 channel contribution in ovx vessels. by Fui C. Yap (611989)

Exogenous hαS decreases neuronal activity and synchronicity of neuronal action potential firing pattern. by G. C. Hassink (4993532)

“…<p>Rat primary cortical cells were cultured for three weeks and subsequently exposed to either 100 μM hαS or BSA. Neuronal activity was recorded using microelectrode arrays. …”

Decreased total protein synthesis in muscle and increased amino acid concentrations in plasma in obese subjects. by Lee Tran (2106961)

Sustained expression of radmis results in decreased cell proliferation and increased cell-cycle exit of NSPCs. by Takahito Yumoto (481671)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…Treatment with Gemcitabine or Cisplatin alone decreased tumor volume to a higher (p < 0.05) extent than OCA alone. …”

The <i>rcan-1</i> rearrangement allele decreases expression of <i>rcan-1</i>. by Yuehui Zhao (3146229)

“…<p>(A) A volcano plot of expression differences between the <i>rcan-1</i> NIL1 and N2* strains. …”